Submitted by web@researchtop... on Mon, 08/02/2010 - 13:16
Efficacy and Safety of Bevacizumab with Capecitabine and Cisplatin in Patients with Advanced Gastric Cancer
| CME test | Downloadable PDF | PowerPoint slides | CME Information and Faculty Disclosures |
| Read Dr Love's original email (from August 3, 2010) | Subscribe to Dr Love's email alerts | ||
Slides from a presentation at ASCO 2010 and transcribed comments from recent interviews with Jaffer A Ajani, MD (7/9/10) and Richard M Goldberg, MD (6/23/10)
Kang Y et al. AVAGAST: A randomized, double-blind, placebo-controlled, phase III study of first-line capecitabine and cisplatin plus bevacizumab or placebo in patients with advanced gastric cancer (AGC). Proc ASCO 2010;Abstract LBA4007.